Journal of Cholesterol and Heart Disease

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

About The Journal Open Access

Journal of Cholesterol and Heart Disease

The cholesterol molecule is a combination of fat and protein that is found in the blood stream. Different permutations of protein and fat make the molecule either healthy or harmful. The liver produces cholesterol and sends it to other parts of the body for the production of hormones and cell membranes. When cholesterol is transported in the bloodstream, it is packed into low-density lipoproteins (LDL), sometimes called the “bad cholesterol.” Although LDL is needed in limited quantities (LDL delivers cholesterol to various parts of the body), a high LDL cholesterol level can dramatically increase risk of a heart attack.

Abnormal levels of cholesterol can lead to cardiovascular disease. High blood cholesterol is generally the reason for most of the cardiovascular disease, as it accumulate in the arteries and narrow it, a condition called Atherosclerosis.

You may submit manuscripts as an email attachment to Disease@eurorendezvous.org or you may submit manuscripts online at https://www.scholarscentral.org/submissions/cholesterol-heart-disease.html

Fast Editorial Execution and Review Process (FEE-Review Process):

Journal of cholesterol and heart disease is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.

h-index

Articles published in Journal of Cholesterol and Heart Disease have been cited by esteemed scholars and scientists all around the world. Journal of Cholesterol and Heart Disease has got h-index 1 , which means every article in Journal of Cholesterol and Heart Disease has got 1 average citations.

Please submit your manuscript to
editorialservice@alliedacademies.org

Just Published Articles View More

Short Communication September 20, 2023

P.1-2

J Cholest Heart Dis: 7(4): 1-2

A comparative analysis of different blood pressure measurement techniques in diagnosing hypertension.

Lars Andersen

DOI:

Short Communication September 14, 2023

P.1-2

J Cholest Heart Dis: 7(4): 1-2

Unraveling the link between heart attack and stroke: Research methodologies and interpretations.

Doreen Ibrahimou*

DOI:

Perspective September 14, 2023

P.1-2

J Cholest Heart Dis: 7(4): 1-2

Role of non-coding RNAs in cardiovascular disease development and progression.

Reinier Windt*

DOI:

Mini Review September 14, 2023

P.1-2

J Cholest Heart Dis: 7(4): 1-2

Microvascular Abnormalities and Hemodynamic Alterations in Arteriovenous Fistulas and Malformations

Budoff Chris*

DOI:

Opinion Article September 14, 2023

P.1-2

J Cholest Heart Dis: 7(4): 1-2

Metabolic alterations and mitochondrial dysfunction in alcoholic cardiomyopathy.

Maya Cristine*

DOI:

Opinion Article September 14, 2023

P.1-2

J Cholest Heart Dis: 7(4): 1-2

Managing the high-risk patient: Optimizing safety and efficacy in complex percutaneous coronary intervention

Andrew Grunberger*

DOI:

Relevant Topics

Get the App